NICOLE ADAMETZ: Open Payments
NPI 1114185139 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 49 payments from 11 companies in 2025. Trend: 2023 $999 · 2024 $1,053 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 15 | $251 |
| ABBVIE INC. | 10 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $154 |
| Janssen Biotech, Inc. | 5 | $99 |
| Phathom Pharmaceuticals, Inc. | 5 | $96 |
| GENZYME CORPORATION | 3 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Medtronic, Inc. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
Products named: REZDIFFRA, TREMFYA, VOQUEZNA, DUPIXENT, EOHILIA, ENTYVIO, RINVOQ, MAVYRET.
Industry payments across PA — which companies pay providers there.
